Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow  0.00% Nasdaq Up 0.52%
Streaming
Ticker Tape: On

More On DIVISLAB.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Divi's Laboratories Limited (DIVISLAB.NS)

-NSE
1,371.85 Up 4.25(0.31%) 2:30AM EDT
Get the big picture on all your investments.
Prev Close:1,367.60
Open:1,376.95
Bid:1,371.85
Ask:1,371.90
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1,363.00 - 1,380.00
52wk Range:905.25 - 1,455.00
Volume:105,544
Avg Vol (3m):163,941
Market Cap:182.09B
P/E (ttm):30.25
EPS (ttm):45.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

» More Headlines for DIVISLAB.NS

Reports

  • No Reports available for DIVISLAB.NS at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, l... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback